NuVasive

8 articles about NuVasive

• Amy Belt Raimundo to Join NuVasive Board of Directors

  8/9/2021

   NuVasive, Inc. today announced the appointment of Amy Belt Raimundo to the Company's Board of Directors, effective August 9, 2021.

• NuVasive to Present at the 41st Annual Cowen Health Care Conference

  2/18/2021

  NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today that management will present at the 41 st Annual Cowen Health Care Conference on Monday, March 1, 2021 at 11:40 a.m. ET / 8:40 a.m. PT .

• NuVasive to Participate as Gold Level Sponsor at SMISS Annual Forum

  10/27/2020

  NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced it will participate as a gold level sponsor at the Society for Minimally Invasive Spine Surgery (SMISS) Annual Forum held virtually from Octo

• NuVasive Announces Conference Call and Webcast of Third Quarter 2020 Results

  10/19/2020

  NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the Company will release its third quarter 2020 earnings results on Thursday, October 29, 2020 after the close of the market.

• NuVasive MaXcess® Retractor Featured in Study Further Validating Prone, Single-Position XLIF® Published in The Journal of Neurosurgery: Spine

  10/5/2020

  NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the results of the study, " Single-position prone lateral approach: cadaveric feasibility study and early clinical experience ," in The Journal of

• NuVasive Expands Precice Portfolio with First-of-its-Kind Plate for Pediatric Limb Lengthening and Reconstruction Procedures

  9/9/2020

   NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the limited availability of the new Precice® Plate for use in limb lengthening and reconstruction procedures from NuVasive Specialized Orthopedics

• NuVasive Becomes First Industry Sponsor of the American Spine Registry to Improve Future of Spine Surgery Through Data-Driven Outcomes

  7/17/2020

   NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, and the American Spine Registry™ (ASR), a national quality improvement registry for spine care, today announced that they have entered into a multi-year sponsorship

• DLA Piper advises NuVasive in its US$400 million convertible senior notes offering

  6/5/2020

  DLA Piper represented advised NuVasive, Inc. (NASDAQ: NUVA), a San Diego -based medical device company that creates and distributes products for surgical treatment of spine disorders, in its offering of US$400 million aggregate principal amount of 1.00% convertible senior notes due 2023. NuVasive also granted to the initial purchasers of